Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It offers medicinal chemistry, pharmacokinetics, clinical and commercial manufacturing, and process development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006.
Sai Life Sciences Limited (SAILIFE) is listed on the NSE in the Healthcare sector, Diagnostics & Research industry. The SAILIFE share price is ₹1,836.80 (+2.90% today), with a market capitalisation of ₹390B and a price-to-earnings (P/E) ratio of 104.5. MarketRipple tracks the SAILIFE investment thesis, the ripple-chain impact of market events on Sai Life Sciences Limited, and the Healthcare sector outlook.
Open
₹1,738.80
High
₹1,897.30
Low
₹1,699.00
Prev. Close
₹1,785.10
52W High
₹1,897.30
52W Low
₹783.85
Day range
₹1,699.00–₹1,897.30
52-week range
₹783.85–₹1,897.30
Volume
10.1M
P/E
104.5
ROE
14.0%
D/E
0.12
Margin
16.1%
Sai Life Sciences Limited (NSE: SAILIFE) is currently trading at ₹1,836.80 (+2.90%).
Sai Life Sciences Limited's market capitalization is ₹390B.
Sai Life Sciences Limited's price-to-earnings (P/E) ratio is 104.5.
Sai Life Sciences Limited operates in the Healthcare sector (Diagnostics & Research).
Analyst consensus on Sai Life Sciences Limited currently reads strongly positive, based on 7 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.